CAMBRIDGE, Mass., April 30, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its presentation at three upcoming investor conferences.
Deutsche Bank 39th Annual Health Care Conference
Wednesday, May 7, 2014 at 12:50 p.m. ET in Boston, MA
Bank of America Merrill Lynch 2014 Health Care Conference
Tuesday, May 13, 2014 at 12:20 p.m. ET in Las Vegas, NV
UBS 2014 Global Healthcare Conference
Tuesday, May 20, 2014 at 3:30 p.m. ET in New York, NY
The audio webcast of the presentation will be available live on the "Investors" section of the company's website located at www.momentapharma.com. A replay of the presentation will be posted on the Momenta website approximately one hour after the event and will be available for two weeks following the presentation.
Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex mixture drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel products.
To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.
Investor Relations Momenta Pharmaceuticals, Inc.